2-chloro-3'-deoxyadenosine
Showing 51 - 75 of >10,000
Human Papillomavirus Infection Trial in Guangzhou, Nanjing, Taiyuan (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58)
Active, not recruiting
- Human Papillomavirus Infection
- Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
- Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)（GARDASIL®）
-
Guangzhou, Guangdong, China
- +2 more
Dec 30, 2022
Alzheimer's Disease, Sleep Disturbance Trial in Albany, New York (Active Lighting Intervention, Control Lighting Intervention)
Recruiting
- Alzheimer's Disease
- Sleep Disturbance
- Active Lighting Intervention
- Control Lighting Intervention
-
Albany, New York
- +1 more
Apr 20, 2023
Colitis, Ulcerative Trial in Cambridge (GSK4381406, Placebo, Indomethacin)
Not yet recruiting
- Colitis, Ulcerative
- GSK4381406
- +2 more
-
Cambridge, United KingdomGSK Investigational Site
Aug 11, 2023
Ulcerative Colitis Trial in Manchester (SOR102, Placebo)
Recruiting
- Ulcerative Colitis
- SOR102
- Placebo
-
Manchester, United KingdomMAC Clinical Research
Oct 6, 2023
Advanced Breast Cancer Trial in Changsha (TQB3909 tablets)
Recruiting
- Advanced Breast Cancer
- TQB3909 tablets
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Mar 16, 2023
Myopia Trial in Ho Chi Minh City (Myatro, Myatro XL)
Not yet recruiting
- Myopia
- Myatro
- Myatro XL
-
Ho Chi Minh City, VietnamUniversity Medical Center HCMC
Apr 5, 2023
Preschool Children Trial (Combined Movement and Storytelling Intervention)
Not yet recruiting
- Preschool Children
- Combined Movement and Storytelling Intervention
- (no location specified)
Aug 25, 2023
Promoting Informed Choice for Breast Cancer Screening: A
Recruiting
- Breast Cancer
- REDS survey
-
Aurora, Colorado
- +1 more
Apr 27, 2023
Acute Clinical Outcomes of Hemorrhagic Myocardial Infarction
Not yet recruiting
- Acute Myocardial Infarction
- (no location specified)
Nov 3, 2023
Streptococcus Pneumoniae Infection Trial in China (13-valent pneumococcal conjugate vaccine (multivalent conjugate), Prevenar
Recruiting
- Streptococcus Pneumoniae Infection
- 13-valent pneumococcal conjugate vaccine (multivalent conjugate)
- Prevenar 13
-
Hechi City, Guangxi Zhuang Autonomous Region, China
- +4 more
Feb 26, 2023
Arterial Stiffness, Hypertension, Cardiovascular Diseases Trial in Prague (Cardiovascular fitness)
Active, not recruiting
- Arterial Stiffness
- +2 more
- Cardiovascular fitness
-
Prague, Czechia
- +1 more
Sep 14, 2023
Burnout, Caregiver, Compassion Fatigue Trial in Halifax (Circuit-based Resistance Training, Circuit-based Resistance Training +
Not yet recruiting
- Burnout, Caregiver
- Compassion Fatigue
- Circuit-based Resistance Training
- +2 more
-
Halifax, Nova Scotia, CanadaPhysical Activity and Cancer (PAC) Lab
May 30, 2023
Alcohol Use Disorder Trial (Prazosin + cyproheptadine, KT110)
Not yet recruiting
- Alcohol Use Disorder
- Prazosin + cyproheptadine
- KT110
- (no location specified)
Nov 27, 2023
Influenza, Human Trial (Investigational aQIVc, licensed QIV1, licensed QIV2)
Not yet recruiting
- Influenza, Human
- Investigational aQIVc
- +2 more
- (no location specified)
Aug 28, 2023
Endometriosis Ovary Trial in Semarang (Dienogest, Depo Medroxyprogesterone acetate, Leuprolide (as Leuprolide Acetate))
Recruiting
- Endometriosis Ovary
- Dienogest
- +3 more
-
Semarang, Central Java, IndonesiaKariadi Hospital
Nov 22, 2023
DFNB9 Trial (OTOV101N+OTOV101C Injections)
Not yet recruiting
- DFNB9
- OTOV101N+OTOV101C Injections
- (no location specified)
Jun 2, 2023
NASH - Nonalcoholic Steatohepatitis Trial in Worldwide (IVA337, Placebo)
Recruiting
- NASH - Nonalcoholic Steatohepatitis
- IVA337
- Placebo
-
Anniston, Alabama
- +352 more
Jan 23, 2023
BCLC A Hepatocellular Carcinoma Non-resectable and Not Amenable for RFA Trial in Bobigny (Durvalumab/Tremelimumab in neoadjuvant
Not yet recruiting
- BCLC A Hepatocellular Carcinoma Non-resectable and Not Amenable for RFA
- Durvalumab/Tremelimumab in neoadjuvant and Durvalumab in adjuvant setting
-
Bobigny, FranceHospitl Avicenne
Sep 13, 2023
Social Anxiety Disorder Trial in New York (Cannabidiol, Placebo)
Recruiting
- Social Anxiety Disorder
- Cannabidiol
- Placebo
-
New York, New YorkNYU Langone Health
Jan 10, 2023
SARS-CoV-2 Trial in Canada, United States (mRNA-1273, Placebo)
Recruiting
- SARS-CoV-2
- mRNA-1273
- +2 more
-
Birmingham, Alabama
- +89 more
Oct 7, 2022
Alcohol Use Disorder Trial in Fort Collins (200mg Cannabidiol oral solution, 30mg Cannabidiol oral solution, Placebo)
Completed
- Alcohol Use Disorder
- 200mg Cannabidiol oral solution
- +2 more
-
Fort Collins, ColoradoColorado State University
Oct 26, 2023
Urinary Incontinence Trial in Denmark, France, United Kingdom (Investigational device - newly developed intermittent catheter,
Not yet recruiting
- Urinary Incontinence
- Investigational device - newly developed intermittent catheter
- +2 more
-
Copenhagen, København Ø, Denmark
- +10 more
Apr 13, 2023
Heart Failure Trial in Lausanne, London (Dapagliflozin tablet, Empagliflozin Tablets)
Not yet recruiting
- Heart Failure
- Dapagliflozin tablet
- Empagliflozin Tablets
-
Lausanne, VD, Switzerland
- +2 more
Aug 24, 2023
Blood Flow Trial in Copenhagen (GIPR antagonist / study tool, GLP-2R antagonist / study tool, Placebo)
Recruiting
- Blood Flow
- GIPR antagonist / study tool
- +2 more
-
Copenhagen, DenmarkRigshospitalet
Nov 2, 2022